Reply to correspondence: Basophil reactivity to BNT162b2 in COVID-19 convalescence.

Labella, MarinaCéspedes, Jose AntonioDoña, InmaculadaShamji, Mohamed HAgache, IoanaMayorga, CristobalinaTorres, Maria José2023-05-032023-05-032022http://hdl.handle.net/10668/19895enBNT162 VaccineBasophilsCOVID-19ConvalescenceHumansImmunoglobulin EReply to correspondence: Basophil reactivity to BNT162b2 in COVID-19 convalescence.research article35770813open access10.1111/all.152081398-9995PMC9350273https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350273https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350273/pdf